Abstract |
|
Authors | G Mustacchi, L Biganzoli, P Pronzato, F Montemurro, M Dambrosio, M Minelli, L Molteni, L Scaltriti |
Journal | Critical reviews in oncology/hematology
(Crit Rev Oncol Hematol)
Vol. 95
Issue 1
Pg. 78-87
(Jul 2015)
ISSN: 1879-0461 [Electronic] Netherlands |
PMID | 25748080
(Publication Type: Journal Article, Review)
|
Copyright | Copyright © 2015 Elsevier Ireland Ltd. All rights reserved. |
Chemical References |
- Anthracyclines
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents
- Quinazolines
- Taxoids
- Lapatinib
- Maytansine
- Capecitabine
- Receptor, ErbB-2
- pertuzumab
- Trastuzumab
- Ado-Trastuzumab Emtansine
|
Topics |
- Ado-Trastuzumab Emtansine
- Anthracyclines
(therapeutic use)
- Antibodies, Monoclonal, Humanized
(therapeutic use)
- Antineoplastic Agents
(therapeutic use)
- Antineoplastic Combined Chemotherapy Protocols
(therapeutic use)
- Brain
(drug effects, pathology)
- Brain Neoplasms
(drug therapy, pathology, secondary)
- Breast
(drug effects, pathology)
- Breast Neoplasms
(drug therapy, pathology)
- Capecitabine
(therapeutic use)
- Chemotherapy, Adjuvant
(methods)
- Female
- Humans
- Lapatinib
- Maytansine
(analogs & derivatives, therapeutic use)
- Neoplasm Metastasis
(drug therapy, pathology)
- Neoplasm Recurrence, Local
(drug therapy, pathology)
- Quinazolines
(therapeutic use)
- Receptor, ErbB-2
(analysis)
- Taxoids
(therapeutic use)
- Trastuzumab
(therapeutic use)
|